<DOC>
	<DOCNO>NCT02184520</DOCNO>
	<brief_summary>This postmarket surveillance study conduct evaluate TRANSITION Stabilization System adjunct fusion treatment acute chronic instability deformity thoracic , lumbar sacral spine . The study involve 360 subject 20 site , treat TRANSITION Stabilization System . The data postmarket surveillance study provide FDA accordance 522 order .</brief_summary>
	<brief_title>A Prospective Randomized Postmarket Clinical Study TRANSITION Stabilization System</brief_title>
	<detailed_description />
	<criteria>Any following acute chronic instability deformity thoracic , lumbar sacral spine : degenerative spondylolisthesis objective evidence neurologic impairment , kyphosis , pseudoarthrosis ( fail previous fusion ) Age 18 old time consent Able understand sign inform consent form Psychosocially , mentally physically able comply protocol Able meet propose followup schedule 6 mo , 12 mo , 24 mo Prior fusion surgery another spinal device implant thoracic , lumbar sacral spine Requires treatment two vertebral level Lytic spondylolisthesis index level ( ) Clinically compromise vertebral body affect level ( ) due current past trauma Sustained pathologic fracture spine hip , include prior fracture trauma vertebral structure thoracic , lumbar , sacral level Morbid obesity define body mass index &gt; 40 , weight 100 lbs ideal body weight Pregnant interested become pregnant within next 2 year Active systemic local infection Known allergy device material titanium , polycarbonate ( PCU ) , polyethylene terepthalate ( PET ) , hydroxyapatite ( HA ) . Taking medication drug know potentially interfere bone/soft tissue healing ( e.g. , steroid , exclude routine NSAIDs ) Systemic disease include AIDS , HIV , Hepatitis C Has active malignancy define history invasive malignancy ( except nonmelanoma skin cancer ) , unless he/she treat curative intent clinical sign symptom malignancy least 5 year Neuromuscular disorder muscular dystrophy , spinal muscular atrophy , amyotrophic lateral sclerosis , etc . Participation investigational device drug clinical trial within 30 day surgery Acute mental illness substance abuse Prisoners</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>